Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibroquel for COVID-19 Hyperinflammation and Pulmonary Fibrosis
NCT04517162Phase 2Unknown
- Start
- Aug 2020
- Primary completion
- Feb 2021
- Countries
- 1
01
Overview
A Phase 2 trial of collagen-polyvinylpyrrolidone in coronavirus disease 2019 (COVID-19), cytokine storm (CRS), pulmonary fibrosis (PF). Status: unknown.
02
Drugs
collagen-polyvinylpyrrolidone
03
Conditions
coronavirus disease 2019 (COVID-19)cytokine storm (CRS)pulmonary fibrosis (PF)
Beyond the preview
Go deeper on NCT04517162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04517162.